First, wild-type Balb/c mice were immunized with irradiated CT26 colon cancer cells, by which CT26-derived antigens were efficiently recognized by immune cells in the tumor antigen-irrelevant naïve mice [24]. This evidence concerns the gene DDX53 and malignant colon neoplasm.